Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ME-609 vs Acyclovir for Recurrent Herpes Labialis in Immunocompromised Patients
NCT00735761Phase 3Completed
- Sponsor
- Medivir
- Start
- Dec 2006
- Primary completion
- Sep 2007
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
01
Overview
A Phase 3 trial of acyclovir + hydrocortisone in herpes labialis, sponsored by Medivir. Started Dec 2006; status: completed.
02
Drugs
acyclovir + hydrocortisone
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00735761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735761.